As only five PPM1D mutant tumors were present in this diverse cohort (5 of 45 total samples; 11%), the whole genome methylation profiling and analysis performed in this study was likely not sufficient to specifically identify differences in DNA methylation patterns in these PPM1D mutant gliomas. Here, PPM1D is linked to central nervous system cancer.